Cathie Wood's ARK Genomic Revolution Stocks Performance Guide: Repare Therapeutics Inc. (RPTX)
RPTX has no dividends.
Table and Chart of RPTX Performance
See what a $1,000 investment in RPTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RPTX Returns | |
|---|---|
| Start Date | Jul-31-2020 |
| Start Price | $23.86 |
| End Date | May-17-2024 |
| End Price | $3.55 |
| # Prices | 47 |
| Min Date | Apr-30-2024 |
| Min Price | $3.10 |
| Max Date | Jan-29-2021 |
| Max Price | $37.11 |
| Total Return | -85.12% |
| Annualized Return | -38.52% |
| Current Value of $1,000 Purchase | $149 |
| Number Returns | 1,081 |
| Average Return | -41.98% |
| Number Profitable Returns | 144 |
| Percent Profitable Returns | 13.32% |
| Number Unprofitable Returns | 937 |
| Percent Unprofitable Returns | 86.68% |
| Profitable to Unprofitable Returns Ratio | 0.15 |
| RPTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $150,681,000 |
| Beta | 0.556 | Price to Sales | 3.01 |
| Earnings per Share | $-2.2300 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 0.726 |
| PRICE DATA | |
| 52 Week High | $13.85 |
| 52 Week Low | $2.98 |
| Analyst Target Price | $15.33 |
| 50-Day Moving Average | $4.037 |
| 200-Day Moving Average | $6.46 |
| FINANCIAL DATA | |
| Revenue per Share | $1.215 |
| Revenue | $51,133,000 |
| Profit Margin | -183.4% |
| Return on Equity | -38.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RPTX Compare Returns with S&P 500
RPTX Trendline Chart
RPTX Moving Average Chart
RPTX Stock Return Map - See Patterns of Gains and Losses
RPTX Stock Returns/Purchase Dates